Rapid Implementation of Electrotherapy in Musculoskeletal Disorder Treatment Enhancing Efficacy of Neurorehabilitation Devices: Fact MR forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Called Microplotters, these systems provide a unique approach to the rapid prototyping of next-generation flexible electronics, including electrode arrays, microfluidic applications, sensors, and graphene-based electronics.
Download 26.67 MB
Brain-Machine-Interface technology is only in its infancy, but scientists believe it may one day allow the severely disabled to perform everyday tasks using brain signals to power artificial limbs.
But some US tech companies have more ambitious interests. They envision a future where BMI will allow them to read people’s thoughts; and where humans will use mind power to interact with their digital devices.
It’s an exciting field, but one fraught with ethical concerns.
Guests
Nathan Copeland – BMI recipient
Assistant Professor Jennifer Collinger – Department of Physical Medicine and Rehabilitation, University of Pittsburgh
Dr Nicole Vincent – Faculty of Transdisciplinary Innovation, University of Technology Sydney
E-Mail
Genova/Lecce (Italy), 28th January 2021 - Understanding and treating brain disorders, such as Alzheimer s disease, addiction, chronic pain, depression and schizophrenia, entails the comprehension of the alterations that may occur in the deep regions of the gray matter. Thanks to the European-funded project DEEPER, an international research consortium, coordinated by IIT-Istituto Italiano di Tecnologia (Italian Institute of Technology), will develop new photonic technologies to access those regions and reveal the molecular and cellular dysfunctions underlying the origin of the disorder. The new technological tools are developed with the goal to directly treat the diseases in a minimally invasive and highly effective way. DEEPER will transfer the technological results from laboratory to market, with the ambition to have an impact to strengthen Europe s industrial position in the biophotonics market.